Inventor · disambiguated record
Andrea Mahr
Also filed as: MAHR ANDREA
349 granted patents·72 pending applications·2,183 citations·filing 2011–2025
99Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH417immatics biotechnology GmbH2Immatics Bioechnologies GmbH1WEINSCHENK TONI1
Top patents by PatentIndex Score
421 records- 0199US11826409B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Nov 28, 2023·6 cites·20 claims
- 0299US11786584B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Oct 17, 2023·4 cites·20 claims
- 0399US11466072B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 11, 2022·17 cites·20 claims
- 0499US11459371B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Oct 4, 2022·6 cites·22 claims
- 0599US11440947B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 13, 2022·6 cites·20 claims
- 0699US11434274B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Sep 6, 2022·6 cites·20 claims
- 0799US11434273B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 6, 2022·6 cites·20 claims
- 0899US11407808B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 9, 2022·12 cites·20 claims
- 0999US11407807B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 9, 2022·17 cites·20 claims
- 1099US11407810B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 9, 2022·6 cites·20 claims
- 1199US11407809B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 9, 2022·6 cites·20 claims
- 1299US11401319B2Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 2, 2022·3 cites·20 claims
- 1399US11365234B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jun 21, 2022·12 cites·20 claims
- 1499US11365235B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jun 21, 2022·6 cites·20 claims
- 1599US11332512B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted May 17, 2022·12 cites·20 claims
- 1699US11324812B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted May 10, 2022·11 cites·20 claims
- 1799US11155597B2Relaxin1 derived peptides for use in immunotherapyIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 26, 2021·17 cites·20 claims
- 1899US11123370B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 21, 2021·4 cites·20 claims
- 1999US11071773B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jul 27, 2021·8 cites·20 claims
- 2099US11065315B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 20, 2021·12 cites·20 claims
- 2199US11058726B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 13, 2021·4 cites·20 claims
- 2299US11058754B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 13, 2021·14 cites·24 claims
- 2399US11027002B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jun 8, 2021·8 cites·20 claims
- 2499US10947294B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 16, 2021·18 cites·30 claims
- 2599US10947293B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 16, 2021·18 cites·28 claims
- 2699US10934338B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 2, 2021·20 cites·20 claims
- 2799US10898558B2Method of treating with a peptideIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·5 cites·26 claims
- 2899US10898557B2Method of treating with a peptideIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·7 cites·24 claims
- 2999US10898560B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·11 cites·20 claims
- 3099US10898559B2Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·11 cites·20 claims
- 3199US10799569B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 13, 2020·14 cites·17 claims
- 3299US10766944B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Sep 8, 2020·18 cites·20 claims
- 3399US10723781B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jul 28, 2020·18 cites·28 claims
- 3499US10526389B2Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jan 7, 2020·14 cites·20 claims
- 3599US10519215B2RELAXIN1 derived peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Dec 31, 2019·18 cites·19 claims
- 3699US10450362B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Oct 22, 2019·25 cites·25 claims
- 3799US10377802B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 13, 2019·83 cites·20 claims
- 3899US10370429B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Aug 6, 2019·24 cites·15 claims
- 3999US10336809B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Jul 2, 2019·30 cites·8 claims
- 4099US10253077B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Apr 9, 2019·94 cites·16 claims
- 4199US10131703B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Nov 20, 2018·28 cites·28 claims
- 4299US10093715B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Oct 9, 2018·27 cites·20 claims
- 4399US10081664B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Sep 25, 2018·30 cites·8 claims
- 4499US10005828B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jun 26, 2018·30 cites·14 claims
- 4599US9994628B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jun 12, 2018·22 cites·19 claims
- 4699US9988432B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Jun 5, 2018·23 cites·13 claims
- 4799US9982031B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted May 29, 2018·27 cites·15 claims
- 4899US9862756B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Jan 9, 2018·35 cites·20 claims
- 4999US9840548B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Dec 12, 2017·29 cites·20 claims
- 5099US9802997B2Peptides and combination of peptides for use in immunotherapy against various tumorsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Oct 31, 2017·46 cites·14 claims
Showing the top 50 of 421 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andrea Mahr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →